MARC record from Internet Archive

LEADER: 03801cam 22006494a 4500
001 ocm50125227
003 OCoLC
005 20200506191222.0
008 011126s2002 enka b 001 0 eng
010 $a 2005283117
040 $aUKM$beng$cNLM$dDLC$dUKM$dC#P$dBAKER$dBTCTA$dYDXCP$dCGC$dIG#$dBDX$dOCLCQ$dOCLCO$dUZ0$dOCLCF$dOCLCO$dOCLCA
015 $aGBA1U3558$2bnb
016 7 $a101144121$2DNLM
019 $a48534027
020 $a9780415273497
020 $a0415273498
035 $a(OCoLC)50125227$z(OCoLC)48534027
042 $apcc
050 00 $aRM301.25$b.P76 2002
060 00 $a2002 E-803
060 10 $aQU 136$bP967168 2002
082 04 $a612.0151$221
245 00 $aProteinase and peptidase inhibition :$brecent potential targets for drug development /$cedited by John H. Smith abd Claire Simons.
260 $aLondon ;$aNew York :$bTaylor & Francis,$c2002.
300 $axvi, 412 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 00 $g1.$tEnzyme classes and mechanisms /$rB. Gerhartz, A. J. Niestroj and H.-U. Demuth --$g2.$tRegulatory mechanisms for proteinase activity /$rS. M. Ellerbroek, Y. Wu and M. S. Stack --$g3.$tMatrix metalloproteinases (MMPs) /$rC. T. Supuran and A. Scozzafava --$g4.$tProteasomes /$rM. Groll and O. Coux --$g5.$tCathepsins /$rB. Rukamp and J. C. Powers --$g6.$tCalpain /$rJ. A. Krauser and J. C. Powers --$g7.$tHuman neutrophil elastase inhibitors /$rP. D. Edwards --$g8.$tThrombin /$rJ. Sturzebecher, J. Hauptmann and T. Steinmetzer --$g9.$tInhibitors of Factor VIIa, Factor IXa, and Factor Xa as anticoagulants /$rR. A. Lazarus and D. Kirchhofer --$g10.$tThe urokinase-type plasminogen activator (uPA) system: a new target for tumor therapy /$rM. Burgle, S. Sperl and J. Sturzebecher /$r[et al.] --$g11.$tProteinases involved in amyloid [beta]-peptide (A[beta]) production and clearance /$rP. Malherbe, G. Huber and F. Grudninger --$g12.$tHerpes virus and cytomegalovirus proteinase /$rR. L. Jarvest and C. E. Dabrowski --$g13.$tHuman rhinovirus 3C proteinase inhibitors /$rP. S. Dragovich and S. E. Webber --$g14.$tAminopeptidases /$rA. Taylor and J. Warner --$g15.$tThe hepatitis C virus NS3 serine-type proteinase /$rR. Bartenschlager and J.-O. Koch --$g16.$tZinc metallopeptidases /$rN. M. Hooper --$g17.$tHIV aspartate proteinase: resistance to inhibitors /$rP. J. Ala and C.-H. Chang --$g18.$tProteases of protozoan parasites /$rP. J. Rosenthal.
650 0 $aProteinase$xInhibitors.
650 0 $aPeptidase$xInhibitors.
650 0 $aPharmacology.
650 12 $aEndopeptidases$xmetabolism.
650 22 $aProtease Inhibitors.
650 22 $aDrug Design.
650 22 $aPeptides$xantagonists & inhibitors.
650 7 $aPharmacology.$2fast$0(OCoLC)fst01060259
650 7 $aProteinase$xInhibitors.$2fast$0(OCoLC)fst01079710
700 1 $aSmith, H. J.,$d1930-
700 1 $aSimons, Claire.
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/fy0602/2005283117.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/enhancements/fy0646/2005283117-d.html
938 $aBaker & Taylor$bBKTY$c189.95$d189.95$i0415273498$n0003920103$sactive
938 $aBrodart$bBROD$n58488537$c$159.95
938 $aBaker and Taylor$bBTCP$n2005283117
938 $aIngram$bINGR$n9780415273497
938 $aYBP Library Services$bYANK$n100286011
029 0 $aNLM$b101144121
029 1 $aAU@$b000023230238
029 1 $aAU@$b000024201107
029 1 $aAU@$b000028631161
029 1 $aIG#$b9780415273497
029 1 $aNZ1$b6627555
029 1 $aYDXCP$b100286011
994 $aZ0$bP4A
948 $hHELD BY P4A - 102 OTHER HOLDINGS